iu Qian, a 45-year-old high school teacher from Chengdu, received a diagnosis of lung adenocarcinoma in early 2023. The news came after months of a persistent dry cough and unexplained weight loss. Lung adenocarcinoma, the most common subtype of non-small cell lung cancer, accounts for roughly 40% of all lung cancer cases in China. For Liu, the diagnosis was a shock—he had never smoked and led what he considered a healthy life. His story is not unique. An increasing number of nonsmokers, particularly in urban areas, are being diagnosed with this form of cancer。challenging long-held assumptions about risk factors.Lung adenocarcinoma originates in the mucus-producing glands of the lungs, often in the outer regions. Symptoms can be subtle—a nagging cough, shortness of breath, or chest discomfort that patients dismiss as a lingering cold. Liu recalled ignoring his cough for six months。attributing it to seasonal allergies. By the time he sought medical attention, imaging revealed a 3-centimeter mass in his right lung. “I thought lung cancer was a smoker’s disease” he said. “No one told me otherwise” His case underscores a critical gap in public awareness: lung adenocarcinoma in nonsmokers is often detected late, reducing treatment options.

Genetic testing revealed that Liu’s tumor carried an EGFR mutation, a finding present in about 50% of Asian patients with lung adenocarcinoma. This discovery opened the door to targeted therapy—daily oral medications that block cancer cell growth. Liu began treatment with osimertinib, a third-generation EGFR inhibitor. Within three months, his tumor shrank by 30%. He continues to teach part-time, though fatigue and occasional nausea persist. His oncologist, Dr. Wang Li, notes that targeted therapies have transformed outcomes for patients like Liu, but access remains uneven. “In major cities。these drugs are available and often covered by insurance” she said. “In rural areas, patients still face barriers”Liu’s experience highlights the importance of early screening for high-risk individuals, even those without a smoking history. Low-dose CT scans can detect lung adenocarcinoma at an early, treatable stage. Yet routine screening for nonsmokers is not standard in China。and awareness among primary care doctors is limited. Liu now advocates for broader education. “If my cough had been taken seriously a year earlier, maybe surgery would have been an option” he said. His advice to others is blunt: “Don’t wait. If something feels off, push for answers” His prognosis remains uncertain, but for now, the targeted therapy is working—a small victory in a journey defined by resilience.